Albert Labs International Corp. (CSE:ABRT)

Canada flag Canada · Delayed Price · Currency is CAD
0.0050
0.00 (0.00%)
Jul 15, 2024, 9:38 AM EST
-83.33%
Market Cap 372.07K
Revenue (ttm) n/a
Net Income (ttm) -2.31M
Shares Out 74.41M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 23,765
Open n/a
Previous Close 0.0050
Day's Range 0.0050 - 0.0050
52-Week Range 0.0050 - 0.0400
Beta 2.16
RSI 39.74
Earnings Date Nov 28, 2025

About Albert Labs International

Albert Labs International Corp., a biopharmaceutical drug discovery company, researches and develops drugs for psychedelic-assisted therapy for patients with urgent and unmet needs in Canada and the United Kingdom. It develops KRN-101, is a solution for cancer-related anxiety. The company is based in Burnaby, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Navchand Jagpal
Country Canada
Stock Exchange Canadian Securities Exchange
Ticker Symbol ABRT
Full Company Profile

Financial Performance

News

There is no news available yet.